Literature DB >> 6130779

The pharmacology of mianserin--an update.

R J Marshall.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6130779      PMCID: PMC1427877          DOI: 10.1111/j.1365-2125.1983.tb05874.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  33 in total

1.  Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain.

Authors:  J Vetulani; F Sulser
Journal:  Nature       Date:  1975-10-09       Impact factor: 49.962

Review 2.  Histaminergic mechanisms in brain.

Authors:  J C Schwartz
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

3.  Development of beta-adrenergic receptor subsensitivity by antidepressants.

Authors:  S P Banerjee; L S Kung; S J Riggi; S K Chanda
Journal:  Nature       Date:  1977-08-04       Impact factor: 49.962

4.  A possible common mechanism of action of antidepressant treatments: reduction in the sensitivity of the noradrenergic cyclic AMP gererating system in the rat limbic forebrain.

Authors:  J Vetulani; R J Stawarz; J V Dingell; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-05       Impact factor: 3.000

5.  Tricyclic antidepressant drugs block histamine H2 receptor in brain.

Authors:  J P Green; S Maayani
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

Review 6.  Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release.

Authors:  S Z Langer
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

7.  Comparative study of the effects of mianserin, a tetracyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes.

Authors:  M Raiteri; F Angelini; A Bertollini
Journal:  J Pharm Pharmacol       Date:  1976-06       Impact factor: 3.765

8.  Different central effects of the 5-HT antagonists mianserine and cyproheptadine.

Authors:  H van Riezen
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-08

9.  Mianserin hydrochloride: peripheral and central effects in relation to antagonism against 5-hydroxytryptamine and tryptamine.

Authors:  B B Vargaftig; J L Coignet; C J de Vos; H Grijsen; I L Bonta
Journal:  Eur J Pharmacol       Date:  1971 Nov-Dec       Impact factor: 4.432

10.  Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.

Authors:  I Goodlet; S E Mireylees; M F Sugrue
Journal:  Br J Pharmacol       Date:  1977-10       Impact factor: 8.739

View more
  9 in total

1.  "First-dose" response to mianserin: effects of age.

Authors:  C G Swift; M R Swift; B Tiplady
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  The atypical antidepressant mianserin exhibits agonist activity at κ-opioid receptors.

Authors:  Maria C Olianas; Simona Dedoni; Pierluigi Onali
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

3.  Serotonin and dopamine modulate aging in response to food odor and availability.

Authors:  Hillary A Miller; Shijiao Huang; Elizabeth S Dean; Megan L Schaller; Angela M Tuckowski; Allyson S Munneke; Safa Beydoun; Scott D Pletcher; Scott F Leiser
Journal:  Nat Commun       Date:  2022-06-07       Impact factor: 17.694

4.  Identification of an Ascaris G protein-coupled acetylcholine receptor with atypical muscarinic pharmacology.

Authors:  Michael J Kimber; Laura Sayegh; Fouad El-Shehabi; Chuanzhe Song; Mostafa Zamanian; Debra J Woods; Tim A Day; Paula Ribeiro
Journal:  Int J Parasitol       Date:  2009-03-25       Impact factor: 3.981

5.  A comparison of the effects of prednisolone and mianserin on ventilatory, exercise and psychometric parameters in patients with chronic obstructive pulmonary disease.

Authors:  A Grove; B J Lipworth; C G Ingram; R A Clark; D P Dhillon
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

6.  The enantioselective synthesis of (S)-(+)-mianserin and (S)-(+)-epinastine.

Authors:  Piotr Roszkowski; Jan K Maurin; Zbigniew Czarnocki
Journal:  Beilstein J Org Chem       Date:  2015-08-28       Impact factor: 2.883

7.  The pharmacokinetics of mianserin suppositories for rectal administration in dogs and healthy volunteers: a pilot study.

Authors:  Shuichi Nawata; Noriko Kohyama; Naoki Uchida; Satoshi Numazawa; Masayuki Ohbayashi; Yasuna Kobayashi; Masanori Iwata; Takanori Nakajima; Hiroshi Saito; Akira Izuka; Toshinori Yamamoto
Journal:  J Pharm Health Care Sci       Date:  2016-05-17

Review 8.  Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective.

Authors:  Madeleine Monique Uys; Mohammed Shahid; Brian Herbert Harvey
Journal:  Front Psychiatry       Date:  2017-08-14       Impact factor: 4.157

Review 9.  Metabolic N-Dealkylation and N-Oxidation as Elucidators of the Role of Alkylamino Moieties in Drugs Acting at Various Receptors.

Authors:  Babiker M Eh-Haj
Journal:  Molecules       Date:  2021-03-29       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.